Charles River Laboratories International Inc
CRL178.050USD
+7.610+4.46%
終値 11/25, 16:00（ET）15分遅れの株価
8.76B時価総額
損失額直近12ヶ月PER
詳細情報 Charles River Laboratories International Inc 企業名
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Charles River Laboratories International Incの企業情報
企業コードCRL
会社名Charles River Laboratories International Inc
上場日Jun 23, 2000
最高経営責任者「CEO」Mr James C. Foster
従業員数18600
証券種類Ordinary Share
決算期末Jun 23
本社所在地251 Ballardvale St
都市WILMINGTON
証券取引所NYSE Consolidated
国United States of America
郵便番号01887
電話番号17812226000
ウェブサイトhttps://www.criver.com/
企業コードCRL
上場日Jun 23, 2000
最高経営責任者「CEO」Mr James C. Foster
Charles River Laboratories International Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
12.88K
+69.56%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.48K
-8.77%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Independent Director
Independent Director
3.96K
+31.35%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
2.59K
+155.42%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
2.41K
+64.49%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
946.00
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
12.88K
+69.56%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.48K
-8.77%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
事業別USD
会社名
収益
比率
DSA
618.03M
59.88%
RMS
213.27M
20.66%
Manufacturing
200.84M
19.46%
地域別USD
会社名
収益
比率
United States
549.86M
53.27%
Europe
281.86M
27.31%
Canada
135.59M
13.14%
Asia Pacific (Region)
54.50M
5.28%
Other
10.33M
1.00%
事業別
地域別
事業別USD
会社名
収益
比率
DSA
618.03M
59.88%
RMS
213.27M
20.66%
Manufacturing
200.84M
19.46%
株主
更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.84%
Wellington Management Company, LLP
6.48%
BlackRock Institutional Trust Company, N.A.
5.73%
Allspring Global Investments, LLC
4.43%
State Street Investment Management (US)
3.72%
他の
67.80%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.84%
Wellington Management Company, LLP
6.48%
BlackRock Institutional Trust Company, N.A.
5.73%
Allspring Global Investments, LLC
4.43%
State Street Investment Management (US)
3.72%
他の
67.80%
種類
株主統計
比率
Investment Advisor/Hedge Fund
44.34%
Investment Advisor
44.17%
Hedge Fund
7.70%
Research Firm
4.24%
Bank and Trust
3.01%
Pension Fund
1.52%
Individual Investor
1.06%
Sovereign Wealth Fund
1.04%
Insurance Company
0.08%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
1387
52.10M
105.85%
-10.18M
2025Q2
1399
56.14M
114.06%
-4.38M
2025Q1
1435
55.38M
112.72%
-5.93M
2024Q4
1423
54.85M
107.26%
-4.35M
2024Q3
1392
53.78M
105.14%
-5.12M
2024Q2
1399
54.00M
104.84%
-4.00M
2024Q1
1393
53.76M
104.37%
-4.04M
2023Q4
1424
53.56M
104.42%
-4.24M
2023Q3
1446
53.56M
104.42%
-3.98M
2023Q2
1427
52.88M
103.32%
-3.95M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
5.80M
11.79%
-293.30K
-4.81%
Jun 30, 2025
Wellington Management Company, LLP
3.77M
7.66%
-517.21K
-12.07%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.75M
5.59%
-156.85K
-5.39%
Jun 30, 2025
Allspring Global Investments, LLC
2.29M
4.66%
+516.52K
+29.11%
Jun 30, 2025
State Street Investment Management (US)
1.86M
3.78%
-43.84K
-2.30%
Jun 30, 2025
Ariel Investments, LLC
1.42M
2.88%
+314.57K
+28.58%
Jun 30, 2025
Harris Associates L.P.
1.16M
2.36%
+1.16M
--
Jun 30, 2025
Geode Capital Management, L.L.C.
1.23M
2.5%
-31.43K
-2.49%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.01M
2.05%
+148.44K
+17.22%
Jun 30, 2025
Invesco Capital Management LLC
1.09M
2.22%
+110.27K
+11.23%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Invesco S&P 500 Equal Weight Health Care ETF
1.68%
Schwab Ariel Opportunities ETF
1.61%
ROBO Global Healthcare Technology & Innovation ETF
1.49%
First Trust NASDAQ Pharmaceuticals ETF
1.41%
VanEck Biotech ETF
1.33%
iShares Health Innovation Active ETF
1.21%
Franklin Genomic Advancements ETF
1.2%
WisdomTree US Value Fund
1%
Principal Quality ETF
0.97%
Invesco S&P 500 High Beta ETF
0.95%
詳細を見る
Invesco S&P 500 Equal Weight Health Care ETF
比率1.68%
Schwab Ariel Opportunities ETF
比率1.61%
ROBO Global Healthcare Technology & Innovation ETF
比率1.49%
First Trust NASDAQ Pharmaceuticals ETF
比率1.41%
VanEck Biotech ETF
比率1.33%
iShares Health Innovation Active ETF
比率1.21%
Franklin Genomic Advancements ETF
比率1.2%
WisdomTree US Value Fund
比率1%
Principal Quality ETF
比率0.97%
Invesco S&P 500 High Beta ETF
比率0.95%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Charles River Laboratories International Incの上位5名の株主は誰ですか？
Charles River Laboratories International Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は5.80M株を保有しており、これは全体の11.79%に相当します。
Wellington Management Company, LLPは3.77M株を保有しており、これは全体の7.66%に相当します。
BlackRock Institutional Trust Company, N.A.は2.75M株を保有しており、これは全体の5.59%に相当します。
Allspring Global Investments, LLCは2.29M株を保有しており、これは全体の4.66%に相当します。
State Street Investment Management (US)は1.86M株を保有しており、これは全体の3.78%に相当します。
The Vanguard Group, Inc.は5.80M株を保有しており、これは全体の11.79%に相当します。
Wellington Management Company, LLPは3.77M株を保有しており、これは全体の7.66%に相当します。
BlackRock Institutional Trust Company, N.A.は2.75M株を保有しており、これは全体の5.59%に相当します。
Allspring Global Investments, LLCは2.29M株を保有しており、これは全体の4.66%に相当します。
State Street Investment Management (US)は1.86M株を保有しており、これは全体の3.78%に相当します。
Charles River Laboratories International Incの株主タイプ上位3種は何ですか？
Charles River Laboratories International Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
Wellington Management Company, LLP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Wellington Management Company, LLP
BlackRock Institutional Trust Company, N.A.
Charles River Laboratories International Inc（CRL）の株式を保有している機関の数はいくつですか？
2025Q3時点で、Charles River Laboratories International Incの株式を保有している機関は1387社あり、保有株式の総市場価値は約52.10Mで、全体の105.85%を占めています。2025Q2と比較して、機関の持ち株は-8.21%増加しています。
Charles River Laboratories International Incの最大の収益源は何ですか？
FY2025Q2において、DSA部門がCharles River Laboratories International Incにとって最大の収益を生み出しており、その金額は618.03Mで、全収益の59.88%を占めています。
